Angiotensin II and oxidative stress in the failing heart
about
Antioxidant-based therapies for angiotensin II-associated cardiovascular diseasesIntracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated CardiomyopathyCharacterization of a murine model of cardiorenal syndrome type 1 by high-resolution Doppler sonography.Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice.Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.Association of Angiotensin-Converting Enzyme Genotype, Insertion/Deletion Polymorphism and Saphenous Vein Graft Atherosclerosis in Iranian Patients.HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activationNovel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.Gene Therapy in Heart Failure.New insights into the non-hemostatic role of von Willebrand factor in endothelial protection.Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.Erythropoietin alleviates post-resuscitation myocardial dysfunction in rats potentially through increasing the expression of angiotensin II receptor type 2 in myocardial tissues.Effect of valsartan on cardiac senescence and apoptosis in a rat model of cardiotoxicity.Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic RatsGhrelin Alleviates Angiotensin II-Induced H9c2 Apoptosis: Impact of the miR-208 Family
P2860
Q27016563-7A76F6D0-B2E1-4A47-BD5D-A3D127F73AB9Q35844633-E4792D8B-A109-42C7-9569-8E7E1548BD07Q35929205-8FB92E74-A339-4ABA-8857-D324D9966484Q36036207-2741E9CA-20C3-427D-97E9-6A61383A3327Q36148599-E2216963-57F7-4744-82B5-ADACADD38ABAQ36402889-26BE83DB-0ED3-4403-8CA1-C1630C506A89Q37166479-05EAE487-2F0C-419A-8262-36FB33926768Q38555026-BAF397EA-FEB1-42FD-8014-56677C19AA1EQ38974621-E22DBAB3-0239-4EBC-9ACA-C2C9352A6F7AQ45861410-D2F3EC1E-B40B-4C8F-AD8C-C5E4CCA10164Q48719553-114DF48E-5C98-4D41-8BF3-58488F22F2F1Q49022015-EB28F28B-902E-463B-8ECC-F3DA4A01FCE2Q49378664-C71E2E53-9597-4AAC-BDBF-826E3F8DEB80Q53148765-DA8D1C1D-0064-4359-B65B-0861A11CE6F1Q58567686-4DD162AE-7650-4D6C-A23D-2F06FEBA8FB1Q58701776-B4183A97-0E7B-497E-81FA-F36CEDD2C153
P2860
Angiotensin II and oxidative stress in the failing heart
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiotensin II and oxidative stress in the failing heart
@en
Angiotensin II and oxidative stress in the failing heart.
@nl
type
label
Angiotensin II and oxidative stress in the failing heart
@en
Angiotensin II and oxidative stress in the failing heart.
@nl
prefLabel
Angiotensin II and oxidative stress in the failing heart
@en
Angiotensin II and oxidative stress in the failing heart.
@nl
P2860
P356
P1476
Angiotensin II and oxidative stress in the failing heart
@en
P2093
Daniela Zablocki
Junichi Sadoshima
P2860
P304
P356
10.1089/ARS.2012.4588
P577
2012-05-03T00:00:00Z